We are live on ! Find out more
PL

Pluribus Labs Portfolio holdings

AUM $54.8M
This Fund
S&P 500
This Quarter Est. Return
-2.43%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$25.2M
AUM Growth
-$69.7M
Cap. Flow
-$68.8M
Cap. Flow %
-273.42%
Top 10 Hldgs %
58.31%
Holding
244
New
16
Increased
13
Reduced
15
Closed
200

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$505K
2
BLK icon
Blackrock
BLK
+$373K
3
PLD icon
Prologis
PLD
+$358K
4
IBM icon
IBM
IBM
+$321K
5
LMT icon
Lockheed Martin
LMT
+$310K

Top Sells

Rank Stock Value
1
MRSH
Marsh
MRSH
+$1.04M
2
PEG icon
Public Service Enterprise Group
PEG
+$879K
3
VZ icon
Verizon
VZ
+$872K
4
QVCGA
QVC Group Inc Series A
QVCGA
+$813K
5
MTZ icon
MasTec
MTZ
+$788K

Sector Composition

Rank Sector Weight
1 Technology 32%
2 Consumer Discretionary 15.05%
3 Healthcare 13.51%
4 Communication Services 13.02%
5 Financials 12.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IBM icon
26
IBM
IBM
$200B
$320K 1.27%
+2,458
New +$321K
V icon
27
Visa
V
$682B
$289K 1.15%
1,305
-925
-41% -$200K
DXCM icon
28
DexCom
DXCM
$29.6B
$283K 1.12%
+2,216
New +$242K
CVX icon
29
Chevron
CVX
$373B
$269K 1.07%
1,651
-97
-6% -$13.9K
PFE icon
30
Pfizer
PFE
$143B
$255K 1.01%
4,935
-5,179
-51% -$269K
MCK icon
31
McKesson
MCK
$98.5B
$254K 1.01%
831
+1
+0.1% +$272
SE icon
32
Sea Limited
SE
$63.7B
$248K 0.99%
+2,071
New +$292K
NXPI icon
33
NXP Semiconductors
NXPI
$67.3B
$245K 0.97%
1,322
+420
+47% +$82.8K
XOM icon
34
ExxonMobil
XOM
$611B
$242K 0.96%
2,930
-936
-24% -$72.8K
DIS icon
35
Walt Disney
DIS
$170B
$229K 0.91%
+1,668
New +$241K
TEL icon
36
TE Connectivity
TEL
$59.3B
$228K 0.91%
+1,744
New +$249K
NFLX icon
37
Netflix
NFLX
$290B
$221K 0.88%
5,910
+1,780
+43% +$74.1K
MDT icon
38
Medtronic
MDT
$106B
$219K 0.87%
+1,975
New +$209K
CMCSA icon
39
Comcast
CMCSA
$85B
$213K 0.85%
+4,553
New +$219K
RMD icon
40
ResMed
RMD
$28.9B
$212K 0.84%
876
+25
+3% +$6.05K
MMM icon
41
3M
MMM
$83.4B
$208K 0.83%
+1,671
New +$222K
CME icon
42
CME Group
CME
$88.5B
$206K 0.82%
+864
New +$203K
META icon
43
Meta Platforms (Facebook)
META
$1.64T
$205K 0.81%
924
-927
-50% -$232K
APD icon
44
Air Products & Chemicals
APD
$65.8B
$204K 0.81%
815
-908
-53% -$233K
A icon
45
Agilent Technologies
A
$37.1B
– –
-4,087
Closed -$652K
AAON icon
46
Aaon
AAON
$9.13B
– –
-8,955
Closed -$474K
ACN icon
47
Accenture
ACN
$87.9B
– –
-1,175
Closed -$487K
ADBE icon
48
Adobe
ADBE
$94.3B
– –
-1,202
Closed -$682K
ADM icon
49
Archer Daniels Midland
ADM
$41.4B
– –
-3,412
Closed -$231K
ADP icon
50
Automatic Data Processing
ADP
$102B
– –
-2,487
Closed -$613K
1
2
3 4 5

Similar funds

BAM
Bruderman Asset Management Locust Valley, New York $55.7M AUM 4.16% 1-Year Est. Return
KIP
Kayak Investment Partners San Francisco, California $52.5M AUM 39.54% 1-Year Est. Return
CRCM
Corbett Road Capital Management Mclean, Virginia $58.4M AUM 5.67% 1-Year Est. Return
FA
Friess Associates Greenville, Delaware $59.9M AUM 3.42% 1-Year Est. Return
LCM
Lafitte Capital Management Austin, Texas $49.5M AUM 27.1% 1-Year Est. Return
IRF
IBM Retirement Fund Armonk, New York $72.1M AUM 12.04% 1-Year Est. Return
ACI
AB CarVal Investors Minneapolis, Minnesota $35.8M AUM 23.8% 1-Year Est. Return
NPGCU
Napier Park Global Capital (US) New York $35M AUM 3.58% 1-Year Est. Return

Pluribus Labs's Q1 2022 Portfolio in Review

As of Q1 2022, Pluribus Labs held 244 positions worth $25.2M, down 73% from $94.8M the previous quarter. Its ten largest holdings account for 58% of the portfolio.

Pluribus Labs withdrew a net $68.8M in Q1 2022, closing 200 positions and reducing 15 holdings. Its most notable exit was Marsh, an estimated $1.04M position sold in full.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Pluribus Labs opened a new position in Merck worth $526K.

  • Pluribus Labs's largest Q1 2022 buy was Merck: 6,405 shares worth $526K.
  • Pluribus Labs added most to Apple in Q1 2022, an estimated $289K increase.
  • Pluribus Labs's biggest Q1 2022 reduction was Johnson & Johnson, cutting an estimated $647K.
  • Pluribus Labs fully exited Marsh in Q1 2022, selling an estimated $1.04M.
  • Pluribus Labs's ten largest holdings make up 58% of its $25.2M portfolio in Q1 2022.
  • Pluribus Labs opened 16 new positions and closed 200 in Q1 2022.
  • Pluribus Labs's portfolio value fell 73% quarter-over-quarter to $25.2M.

Based on Pluribus Labs's 13F filing for Q1 2022, filed 16 May 2022.